Safety Evaluation of a Q-fever Vaccine, NDBR 105

Q Fever Clinical Trial

Official title:
Continued Evaluation of the Safety of Q Fever Vaccine, Phase I, Inactivated, Freeze Dried, NDBR 105, in Those at Risk of Exposure to Coxiella Burnetii, A Phase 2 Study

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the safety of Q Fever vaccine, NDBR 105, and collect data on incidence of occupational Q Fever infection in at risk personnel.

Clinical Trial Description

Study Objectives:

1. Continue to collect and assess safety data on Q Fever Vaccine, Phase I, Inactivated, Freeze-Dried, NDBR 105, and 2) Provide vaccine that potentially protects personnel at risk for occupational exposure to Q Fever and collect data on incidence of occupational Q Fever infection (subclinical and clinical) in immunized personnel. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00584454
Study type	Interventional
Source	U.S. Army Medical Research and Development Command
Contact
Status	Completed
Phase	Phase 2
Start date	February 2006
Completion date	June 2014

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03334019` - Prevalence and Risk Factors for Coxiella Burnetii Seropositivity (Q Fever) Among Adults in Western France
Active, not recruiting	`NCT01450501` - Chronic Q-fever in Patients With an Abdominal Aortic Disease (QAAD-study)	N/A
Recruiting	`NCT01095328` - A Screening Strategy for Q Fever Among Pregnant Women	N/A
Completed	`NCT02822807` - Q Fever and Auto-immunity	N/A
Completed	`NCT02898402` - Study on Seroprevalence and Risk Factors of Coxiella Burnetii (Q Fever) in the South of Reunion Island	N/A
Withdrawn	`NCT02092142` - Safety and Immunogenicity of Q Fever Vaccine	Phase 2
Completed	`NCT01318356` - The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment	Phase 4